Emtricitabine (Emtriva)

Published July 07, 2003; Updated October 2016
Susa Coffey, MD
Selected Reference
4. Campo R, Dejesus E, Bredeek UF, et al. SWIFT: Prospective 48 week study to evaluate efficacy and safety of switching to emtricitibine/tenofovir from lamivudine/abacavir in virologically suppressed HIV-1 infected patients on a boosted protease inhibitor containing antiretroviral regimen. Clin Infect Dis. 2013 Jan 29.